Preoperative antiplatelet and statin treatment was not associated with reduced myocardial infarction after high-risk vascular operations in the Vascular Quality Initiative Randall R. De Martino, MD, MS, Adam W. Beck, MD, Andrew W. Hoel, MD, John W. Hallett, MD, Shipra Arya, MD, Gilbert R. Upchurch, MD, Jack L. Cronenwett, MD, Philip P. Goodney, MD, MS Journal of Vascular Surgery Volume 63, Issue 1, Pages 182-189.e2 (January 2016) DOI: 10.1016/j.jvs.2015.08.058 Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Fig Preoperative medication status within each cardiac risk stratum. AP, Antiplatelet agent (aspirin or P2Y12a antagonist). Journal of Vascular Surgery 2016 63, 182-189.e2DOI: (10.1016/j.jvs.2015.08.058) Copyright © 2016 Society for Vascular Surgery Terms and Conditions